| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.06B | 35.14B | 34.78B | 36.50B | 34.77B | 30.87B |
| Gross Profit | 7.59B | 7.53B | 7.23B | 7.81B | 6.48B | 6.34B |
| EBITDA | 2.77B | 2.76B | 2.79B | 3.08B | 1.90B | 1.92B |
| Net Income | 1.43B | 1.43B | 1.51B | 1.76B | 863.13M | 1.00B |
Balance Sheet | ||||||
| Total Assets | 24.78B | 25.87B | 24.96B | 23.97B | 22.48B | 21.54B |
| Cash, Cash Equivalents and Short-Term Investments | 7.99B | 8.87B | 7.58B | 6.59B | 5.00B | 5.05B |
| Total Debt | 1.30B | 1.32B | 1.60B | 1.71B | 1.83B | 1.99B |
| Total Liabilities | 6.23B | 7.05B | 7.23B | 7.40B | 7.26B | 6.87B |
| Stockholders Equity | 16.88B | 17.11B | 16.15B | 15.10B | 13.86B | 13.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.14B | 1.60B | 2.09B | 396.09M | 704.29M |
| Operating Cash Flow | 0.00 | 2.43B | 1.84B | 2.20B | 550.67M | 2.16B |
| Investing Cash Flow | 0.00 | -509.56M | -119.69M | -97.46M | -42.75M | -1.22B |
| Financing Cash Flow | 0.00 | -833.93M | -729.54M | -512.25M | -565.81M | -625.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥11.26B | 8.90 | ― | 4.12% | -1.52% | -7.80% | |
75 Outperform | ¥14.16B | 4.37 | ― | 3.90% | -1.72% | 168.62% | |
74 Outperform | ¥12.37B | 7.26 | ― | 2.91% | -3.24% | -26.11% | |
74 Outperform | ¥9.26B | 8.07 | ― | 3.19% | 5.38% | 5.29% | |
66 Neutral | ¥37.62B | 9.29 | ― | 0.55% | 7.65% | ― | |
62 Neutral | ¥20.78B | 4.87 | ― | 4.58% | 34.99% | 468.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |